Nymox Pharmaceutical Corp (NYMX)
Nymox Pharmaceutical Corp (NYMX) was listed on Nasdaq from November 26, 1997 and stopped trading under the symbol NYMX on July 7, 2023.
- Listed On
- Nasdaq
- Listed Since
- November 26, 1997
- Stopped Trading
- July 7, 2023
- Employees
- 3
About Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. It markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. It operates in a single segment, which is research and development of products for the aging population. The company's geographical segments include Canada, United States, and Europe.
Institutional ownership
In 13F filings for the quarter ended December 31, 2021, 1 institution reported holding NYMX, with 100 shares worth $0 in aggregate. The largest reported holder was Steward Financial Group, with 100 shares. Of the 1 largest holders listed below, 1 opened a new position in NYMX during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Steward Financial Group | 100 | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is NYMX?
Nymox Pharmaceutical Corp (NYMX) was listed on Nasdaq from November 26, 1997 and stopped trading under the symbol NYMX on July 7, 2023.
Who are the largest institutional holders of NYMX?
In 13F filings for the quarter ended December 31, 2021, the largest reported holders of NYMX were Steward Financial Group.
How many institutions own NYMX?
1 institution reported a position in NYMX for the quarter ended December 31, 2021, worth $0 in total.
Did institutions buy or sell NYMX last quarter?
Of the 1 largest reported holders, 1 opened a new position in NYMX during the quarter. Every reported holder and its change is on the SentiSense ownership page for NYMX.
Every reported institutional holder, plus insider and congressional trades in NYMX, on SentiSense.